HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ABP

Abpro Holdings Inc

Last Close
Feb 06  •  04:00PM ET
1.50
Dollar change
0.00
Percentage change
0.00 %
Healthcare • Biotechnology • USA • NASD
Held by: VXF
Scroll to Statements
Index- P/E- EPS (ttm)-12.45 Insider Own36.26% Shs Outstand2.67M Perf Week-22.28%
Market Cap4.07M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float1.73M Perf Month-66.29%
Enterprise Value4.43M PEG- EPS next Q- Inst Own2.73% Short Float0.28% Perf Quarter-72.97%
Income-22.04M P/S- EPS this Y- Inst Trans-9.30% Short Ratio0.18 Perf Half Y-79.12%
Sales0.00M P/B- EPS next Y- ROA-248.15% Short Interest0.00M Perf YTD-64.54%
Book/sh-6.04 P/C11.97 EPS next 5Y- ROE- 52W High34.65 -95.67% Perf Year-94.95%
Cash/sh0.13 P/FCF- EPS past 3/5Y-2359.24% - ROIC- 52W Low1.44 4.17% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility11.31% 14.35% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM-95.93% Oper. Margin- ATR (14)0.37 Perf 10Y-
Dividend Ex-Date- Quick Ratio0.07 Sales Y/Y TTM- Profit Margin- RSI (14)21.39 Recom3.00
Dividend Gr. 3/5Y- - Current Ratio0.07 EPS Q/Q48.60% SMA20-44.27% Beta0.04 Target Price60.00
Payout- Debt/Eq- Sales Q/Q- SMA50-64.75% Rel Volume0.86 Prev Close1.50
Employees6 LT Debt/Eq- EarningsSep 03 SMA200-75.37% Avg Volume27.51K Price1.50
IPOMar 09, 2022 Option/ShortNo / Yes EPS/Sales Surpr.0.00% - Trades Volume23,563 Change0.00%
Jan-15-26 07:00AM
Abpro's Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference
(GlobeNewswire) -8.60%
Jan-06-26 07:00AM
Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72
(GlobeNewswire) +19.75%
Dec-15-25 07:00AM
Abpro Holdings Announces Submission of an IND Application to Initiate a Phase 1 Clinical Trial of T cell engager ABP-102/CT-P72 for HER2-positive Cancers
(GlobeNewswire)
Dec-09-25 07:00AM
Abpro Granted Nasdaq Listing Extension to Pursue Compliance and Strategic Objectives
(GlobeNewswire) +6.26%
Nov-04-25 09:15AM
Abpro and Celltrion to Present Preclinical Data for CT-P72/ABP-102 at SITC 2025, Highlighting a Next-Generation HER2xCD3 T-Cell Engager
(GlobeNewswire)
07:00AM Loading…
Nov-03-25 07:00AM
Abpro Announces 1-for-30 Reverse Stock Split Effective November 3, 2025
(GlobeNewswire)
Aug-05-25 10:30AM
BC-Most Active Stocks
(Associated Press Finance) +15.81%
Jul-28-25 10:30AM
BC-Most Active Stocks
(Associated Press Finance)
Jul-25-25 10:30AM
BC-Most Active Stocks
(Associated Press Finance) +18.53%
Jul-17-25 10:30AM
BC-Most Active Stocks
(Associated Press Finance) -10.08%
Apr-27-25 02:00PM
Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager
(GlobeNewswire)
Mar-25-25 04:30PM
Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025
(GlobeNewswire) -9.45%
Mar-10-25 06:34PM
Abpro Statement on the Departure of Former CEO Ian Chan
(GlobeNewswire) -5.10%
Dec-12-24 04:05PM
Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing
(GlobeNewswire)
Jun-13-24 04:15PM
Atlantic Coastal Acquisition Corp. II Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q
(PR Newswire)
08:00AM Loading…
Jan-22-24 08:00AM
Abpro Announces Filing of Registration Statement on Form S-4 in Connection with Business Combination Agreement with Atlantic Coastal Acquisition Corp. II
(GlobeNewswire)
Oct-18-23 04:15PM
Atlantic Coastal Acquisition Corp. II Announces Extension of Business Combination Period and Additional Contribution to Trust Account
(PR Newswire)
Sep-06-23 08:11AM
IMPORTANT: Atlantic Coastal Acquisition Corp. Files Definitive Proxy Statement in Connection with Plan to Extend the Amount of Time the Company has to Consummate a Business Combination
(PR Newswire)
Aug-25-23 04:11PM
Atlantic Coastal Acquisition Corp. Announces Plans to Extend Deadline to Complete Initial Business Combination.
(PR Newswire)
Aug-18-23 04:11PM
Atlantic Coastal Acquisition Corp. Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination
(PR Newswire)
May-30-23 05:00PM
Atlantic Coastal Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q
(PR Newswire)
Abpro Holdings, Inc. operates as a capital pool company. The company was founded in 2004 and is headquartered in Woburn, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Suk Jin Wook (Miles)CEO and ChairmanJul 31 '25Buy0.2872,03520,170718,512Aug 04 05:22 PM
Suk Jin Wook (Miles)CEO and ChairmanMay 19 '25Buy0.2616,2004,212146,477May 19 08:37 PM
Suk Jin Wook (Miles)CEO and ChairmanApr 29 '25Buy0.254,3251,081130,277May 01 04:21 PM
Suk Jin Wook (Miles)CEO and ChairmanApr 24 '25Buy0.3426,5429,024125,902Apr 25 04:58 PM
Suk Jin Wook (Miles)CEO and ChairmanApr 23 '25Buy0.287,4602,08999,360Apr 25 04:58 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.